Physician profile
Gary S Cohen
NPI 1891784559
$288.03
in general payments reported to CMS, 2019-2025
10 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.70 · 2020: $17.92 · 2021: $14.21 · 2022: $21.18 · 2023: $38.47 · 2024: $43.48 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $52.42 | 2025 | Austedo Xr |
| Abbott Laboratories | $46.53 | 2025 | Freestyle Libre 3 |
| Siemens Medical Solutions USA, INC. | $40.79 | 2023-2024 | Ai-Rad Companion (Musculoskeletal), Naeotom Alpha |
| Kowa Pharmaceuticals America, INC. | $38.91 | 2019-2021 | |
| Baxter Healthcare | $29.12 | 2025 | Floseal |
| Pfizer INC. | $21.18 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.92 | 2020 | |
| Trisalus Life Sciences, INC. | $14.74 | 2023 | Trinav Infusion System |
| Hologic Sales and Service, LLC | $14.20 | 2024 | Brevera Breast Biopsy System, 3dimensions, 3dquorum |
| Merit Medical Systems INC | $12.22 | 2024 | Corvocet Biopsy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.